摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(4-chlorophenyl)-2,4-dimethylthiazole | 1227469-87-5

中文名称
——
中文别名
——
英文名称
5-(4-chlorophenyl)-2,4-dimethylthiazole
英文别名
5-(4'-chlorophenyl)-2,4-dimethyl-1,3-thiazole;5-(4-Chlorophenyl)-2,4-dimethyl-1,3-thiazole
5-(4-chlorophenyl)-2,4-dimethylthiazole化学式
CAS
1227469-87-5
化学式
C11H10ClNS
mdl
——
分子量
223.726
InChiKey
LCEPYWFFHOSUAX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    41.1
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    三氟甲磺酸-4-氯苯醚potassium 2,4-dimethyl-1,3-thiazole-5-carboxylate2,6-二甲基吡啶三苯基膦 、 silver carbonate 、 palladium dichloride 作用下, 以 N-甲基吡咯烷酮 为溶剂, 反应 16.0h, 以80%的产率得到5-(4-chlorophenyl)-2,4-dimethylthiazole
    参考文献:
    名称:
    Ag / Pd催化的芳基三氟甲磺酸酯与芳族羧酸盐的低温脱羧交叉偶联
    摘要:
    在比最知名的铜催化剂低50°C的条件下,催化银(I)/钯(II)系统可在低至120°C的温度下将芳族羧酸酯与芳基三氟甲磺酸酯进行脱羧交叉偶联。值得注意的是,多氯代芳烃羧酸酯和许多杂环芳烃羧酸酯首次以高收率转化。FG =功能组。
    DOI:
    10.1002/chem.200903319
点击查看最新优质反应信息

文献信息

  • AZETIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS
    申请人:Aissaoui Hamed
    公开号:US20100222600A1
    公开(公告)日:2010-09-02
    The invention relates to novel azetidine compounds of formula (I), wherein R 1 , R 2 , and X are as described in the description and their use as orexin receptor antagonists.
    这项发明涉及一种新型的式(I)的氮杂环丙烷化合物,其中R1、R2和X如描述中所述,并且它们作为促进睡眠的药物受体拮抗剂的用途。
  • 3-HETEROARYL (AMINO OR AMIDO)-1-(BIPHENYL OR PHENYLTHIAZOLYL) CARBONYLPIPERIDINE DERIVATIVES AS OREXIN RECEPTOR INHIBITORS
    申请人:Aissaoui Hamed
    公开号:US20100069418A1
    公开(公告)日:2010-03-18
    The invention relates to piperidine compounds of formula (I) wherein X-R 1 represents —N(H)-pyrimidinyl, wherein said pyrimidinyl is unsubstituted or mono-substituted wherein the substituent is selected from (C 1-4 )alkyl or halogen, or X-R 1 represents —NH—C(O)-heterocyclyl, wherein the heterocyclyl is selected from benzofuranyl and imidazo[2,1-b]-thiazolyl, wherein said heterocyclyl is unsubstituted or independently mono-, di-, or tri-substituted wherein the substituents are independently selected from (C 1-4 )alkyl; A represents a phenyl- or thiazolyl-group, wherein the phenyl or thiazolyl is unsubstituted or mono-substituted with (C 1-4 )alkyl; B represents a phenyl-group, wherein the phenyl is unsubstituted or mono-, or di-substituted, wherein the substituents are independently selected from the group consisting of (C 1-4 )alkyl, (C 1-4 )alkoxy, trifluoromethyl, cyano and halogen; to pharmaceutically acceptable salts thereof, and to the use of such compounds use as medicaments, especially as orexin receptor antagonists.
    该发明涉及式(I)的哌啶化合物,其中X-R1代表-N(H)-嘧啶基,其中所述的嘧啶基未取代或单取代,取代基选自(C1-4)烷基或卤素,或者X-R1代表-NH-C(O)-杂环基,其中所述的杂环基选自苯并呋喃基和咪唑[2,1-b]-噻唑基,其中所述的杂环基未取代或独立单取代、双取代或三取代,取代基独立选自(C1-4)烷基;A代表苯基或噻唑基,其中所述的苯基或噻唑基未取代或单取代为(C1-4)烷基;B代表苯基,其中所述的苯基未取代或单取代、双取代,取代基独立选自(C1-4)烷基、(C1-4)烷氧基、三甲基、基和卤素;以及其药学上可接受的盐,以及将这类化合物用作药物,特别是用作促觉醒素受体拮抗剂。
  • 3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
    申请人:Aissaoui Hamed
    公开号:US20100016401A1
    公开(公告)日:2010-01-21
    The invention relates to 3-aza-bicyclo[3.1.0]hexane derivatives of formula (I) wherein A, B, n, X, and R 1 are as described in the description, and salts thereof, and their use as orexin receptor antagonists.
    这项发明涉及式(I)的3-aza-双环[3.1.0]己烷生物,其中A、B、n、X和R1如描述中所述,以及其盐,以及它们作为促进睡眠的荷尔蒙受体拮抗剂的用途。
  • Camphyl-based α-diimine palladium complexes: highly efficient precatalysts for direct arylation of thiazoles in open-air
    作者:Fu-Min Chen、Dong-Dong Lu、Li-Qun Hu、Ju Huang、Feng-Shou Liu
    DOI:10.1039/c7ob00856b
    日期:——
    Based on the strategy of the development of phosphine-free palladium-catalyzed direct C–H arylation, a series of camphyl-based α-diimine palladium complexes bearing sterically bulky substituents were synthesized and characterized. The palladium complexes were applied for the cross-coupling of thiazole derivatives with aryl bromides. The effect of the sterically bulky substituent on the N-aryl moiety
    基于开发无膦催化的直接CHH芳基化的策略,合成并表征了一系列基于迷迭香的带有空间庞大取代基的α-二亚胺配合物。配合物用于噻唑生物与芳基化物的交叉偶联。筛选了体积庞大的取代基对N-芳基部分的影响以及反应条件。在最佳方案下,在露天条件下,在含量为0.2 mol%的情况下,可以将宽范围的芳基化物与噻唑平稳地偶联,并获得良好或优异的收率。
  • A convenient phosphine-free palladium-catalyzed direct arylation of thiazole under mild aerobic conditions
    作者:Xiao-Xi He、Yan-Fang Li、Ju Huang、Dong-Sheng Shen、Feng-Shou Liu
    DOI:10.1016/j.jorganchem.2015.12.009
    日期:2016.2
    A series of bulky amine palladium complexes [(Ar-NH2)2PdCl2]} were synthesized and characterized. The catalytic activity of the palladium complexes was evaluated via the direct C–H arylation of thiazoles with aryl bromides in aerobic conditions at 80–100 °C. Under the optimal conditions, 0.5–0.05 mol% of the bulky palladium complexes were found to be very efficient and produced the desired cross-coupling
    合成并表征了一系列大体积的胺络合物[(Ar-NH 2)2 PdCl 2 ]}。在80–100°C的好氧条件下,通过噻唑与芳基化物的直接C–H芳基化评估配合物的催化活性。在最佳条件下,发现0.5-0.05 mol%的大体积络合物非常有效,可以高收率生产出所需的交叉偶联产物。
查看更多